Skip to main content

ANGIODYNAMICS INC

corporate_fare Company Profile

ANGIODYNAMICS INC

ANGO·NASDAQ·Life Sciences·CIK 0001275187

ANGIODYNAMICS INC designs, manufactures, and sells medical products and technologies to aid clinicians in treating patients with cardiovascular disease and cancer. The company's strategy focuses on innovative research and development, expanding clinical and regulatory pathways, and customer-centric sales. Founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics began manufacturing and shipping products in the early 1990s. Its headquarters are in Latham, N.Y., with primary manufacturing in Queensbury. Initially focused on interventional radiology products, the company became known for diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Over the years, AngioDynamics expanded through acquisitions. Key acquisitions include RITA Medical Systems in January 2007, Oncobionic in May 2008, Diomed assets in June 2008, Vortex Medical, Inc. in October 2012, Microsulis Medical Limited assets in January 2013, and Clinical Devices in August 2013. These additions brought product lines such as ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products, and venous products. The company acquired Navilyst Medical's Fluid Management business in May 2012, selling it to Medline Industries, Inc. in May 2019. In August 2018, it acquired the BioSentry product line from Surgical Specialties, LLC, which was sold to Merit Medical Systems, Inc. in June 2023. In September 2018, AngioDynamics acquired RadiaDyne, including endorectal and vaginal balloons. On October 2, 2019, the company acquired Eximo Medical, Ltd. and its 355nm laser atherectomy technology (now Auryon) for Peripheral Artery Disease. On December 17, 2019, it acquired the C3 Wave tip location asset from Medical Components Inc., and on July 27, 2021, the Camaro Support Catheter asset from QX Medical, LLC.

ANGIODYNAMICS INC (NASDAQ:ANGO) is a publicly traded company in the Life Sciences sector. Wiseek monitors ANGO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Financial Snapshot

Fiscal year ended May 31, 2026
Revenue
$320.17M
Net Income
-$36.74M
Diluted EPS
-$0.88
Op. Cash Flow
$3.09M
Free Cash Flow
$508K
Gross Profit
$174.89M
Operating Income
-$39.93M
Cash & Equivalents
$53.86M
Debt / Equity
0.00×
Net Margin
-11.5%
Shares Outstanding
41.7M sh
Source: 10-K · filed 2026-07-14 · accession 0001628280-26-048138
Browse all tickers starting with A →
$13.59
52-week range · as of 2026-07-14 $8.36 – $13.99
Market cap
$561.71M
Volume
333K (0.7× avg)
3-mo avg 504.4K
Live data · 2026-07-27 00:56 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ANGO - Latest Insights